Status:
COMPLETED
Role of OMT in the Management of the Persistent Post-COVID-19 Symptoms
Lead Sponsor:
A.T. Still University of Health Sciences
Collaborating Sponsors:
American Osteopathic Association
Conditions:
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to determine the feasibility of conducting a large-scale study on the effect of using osteopathic manipulative treatment (OMT) to treat patients with post-COVID...
Eligibility Criteria
Inclusion
- at least one symptom of post-COVID-19 (eg, fatigue, dyspnea, anosmia, arthralgia, headache, sleep disturbances, anxiety/depression, or other problems related to mental health) which was new after diagnosis with COVID-19 and has persisted for at least 4 weeks after diagnosis
Exclusion
- unable to speak, read, and write in English
- not mentally competent to give informed consent
- inability to complete surveys/questionnaires online
Key Trial Info
Start Date :
September 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 10 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06016543
Start Date
September 18 2023
End Date
July 10 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Osteopathic Manipulative Medicine Gutensohn Clinic
Kirksville, Missouri, United States, 63501